Table 2.
Correlation between miR-17-5p expression and clinicopathologic features of TNBC patients
| Characteristics | n | miR-17-5p | P value | |
|---|---|---|---|---|
| High | Low | |||
| Age (y) | ||||
| ≤ 50 | 63 | 14 (22%) | 49 (78%) | 1.000 |
| > 50 | 42 | 9 (21%) | 33 (79%) | |
| Tumour Size | ||||
| ≤ 2 cm | 19 | 8 (42%) | 11 (58%) | 0.030* |
| > 2 cm | 86 | 15 (17%) | 71 (83%) | |
| Pathological type | ||||
| Invasive ductal carcinomas | 93 | 19 (20%) | 74 (80%) | 0.292 |
| Others | 12 | 4 (33%) | 8 (67%) | |
| TNM Stage | ||||
| I | 6 | 3 (50%) | 3 (50%) | 0.022* |
| II | 34 | 11 (32%) | 23 (68%) | |
| III | 65 | 9 (14%) | 56 (86%) | |
| Lymph node metastasis | ||||
| 0–4 | 45 | 15 (33%) | 30 (67%) | 0.050 |
| 5–8 | 39 | 6 (15%) | 33 (85%) | |
| ≥ 9 | 21 | 2 (10%) | 19 (90%) | |
| Relapse | ||||
| No | 67 | 18 (27%) | 49 (73%) | 0.141 |
| Yes | 38 | 5 (13%) | 33 (87%) | |
*means P < 0.05; Fisher exact test